FI875645A - Menetelmä nestemäisen annostelumuodon valmistamiseksi farmaseuttisesti aktiivisen aineen oraalista antoa varten - Google Patents

Menetelmä nestemäisen annostelumuodon valmistamiseksi farmaseuttisesti aktiivisen aineen oraalista antoa varten Download PDF

Info

Publication number
FI875645A
FI875645A FI875645A FI875645A FI875645A FI 875645 A FI875645 A FI 875645A FI 875645 A FI875645 A FI 875645A FI 875645 A FI875645 A FI 875645A FI 875645 A FI875645 A FI 875645A
Authority
FI
Finland
Prior art keywords
active substance
pharmaceutically active
dosage form
oral administration
preparing
Prior art date
Application number
FI875645A
Other languages
English (en)
Swedish (sv)
Other versions
FI875645A0 (fi
FI94923B (fi
FI94923C (fi
Inventor
Kjell Johan Mattsson
Alf Gunnar Martin Nicklasson
Rolf Ivar Sjoeqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of FI875645A0 publication Critical patent/FI875645A0/fi
Publication of FI875645A publication Critical patent/FI875645A/fi
Publication of FI94923B publication Critical patent/FI94923B/fi
Application granted granted Critical
Publication of FI94923C publication Critical patent/FI94923C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI875645A 1986-12-22 1987-12-21 Menetelmä nestemäisen annostelumuodon valmistamiseksi farmaseuttisesti aktiivisen aineen oraalista antoa varten FI94923C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8605515 1986-12-22
SE8605515A SE8605515D0 (sv) 1986-12-22 1986-12-22 A liquid dosage form for oral administration of a pharmaceutically active substance

Publications (4)

Publication Number Publication Date
FI875645A0 FI875645A0 (fi) 1987-12-21
FI875645A true FI875645A (fi) 1988-06-23
FI94923B FI94923B (fi) 1995-08-15
FI94923C FI94923C (fi) 1995-11-27

Family

ID=20366721

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875645A FI94923C (fi) 1986-12-22 1987-12-21 Menetelmä nestemäisen annostelumuodon valmistamiseksi farmaseuttisesti aktiivisen aineen oraalista antoa varten

Country Status (17)

Country Link
US (1) US5085868A (fi)
EP (1) EP0273890B1 (fi)
JP (1) JP2778030B2 (fi)
AT (1) ATE87471T1 (fi)
AU (1) AU609753B2 (fi)
CA (1) CA1317883C (fi)
DE (1) DE3785167T2 (fi)
DK (1) DK668787A (fi)
ES (1) ES2039480T3 (fi)
FI (1) FI94923C (fi)
GR (1) GR3007542T3 (fi)
HK (1) HK66396A (fi)
IE (1) IE60149B1 (fi)
IL (1) IL86607A (fi)
NO (1) NO177177C (fi)
PH (1) PH25287A (fi)
SE (1) SE8605515D0 (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476447A (en) * 1968-03-28 1969-11-04 Westinghouse Electric Corp Self-aligning hydrostatic bearing
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
DE68906461T2 (de) * 1988-06-07 1993-10-21 Abbott Lab Feste Arzneidosis in Form eines Tablettentriturats sowie Verfahren zu deren Herstellung.
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5306507A (en) * 1992-03-26 1994-04-26 Mallinckrodt Specialty Chemicals Company Process and composition containing pamabrom and pyrilamine maleate
US5464625A (en) * 1992-05-08 1995-11-07 Monell Chemical Senses Center Non-toxic methods of repelling rodents from materials susceptible to rodent consumption
US5635200A (en) * 1992-10-16 1997-06-03 Glaxo Group Limited Taste-making compositions of ranitidine
ES2194863T3 (es) * 1992-11-30 2003-12-01 Kv Pharm Co Materiales farmaceuticos con enmascarado de sabor.
WO1997018245A1 (en) * 1995-11-14 1997-05-22 Farmarc Nederland B.V. Complex of naproxen and beta-cyclodextrin
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
SE9702338D0 (sv) * 1997-06-18 1997-06-18 Astra Ab An analytical method and industrial process including the same
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
JP2002530322A (ja) * 1998-11-25 2002-09-17 シーマ・ラブス・インコーポレイテッド 味隠蔽迅速放出コーティング系
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
CN1189159C (zh) 2000-05-05 2005-02-16 欧莱雅 含水溶性美容活性组分水性核的微胶囊及含其的组合物
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
WO2003084518A2 (fr) 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules de principes actifs
ATE407674T1 (de) 2002-04-09 2008-09-15 Flamel Tech Sa Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
AU2003249904A1 (en) * 2002-07-02 2004-01-23 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
WO2004108092A2 (en) * 2003-06-05 2004-12-16 P3 Laboratories, Inc. Tannate compositions and methods of use
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US8473062B2 (en) * 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) * 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
GB2529605B (en) * 2014-06-03 2018-03-21 Essential Pharmaceuticals Ltd Pharmaceutical composition
GB201804621D0 (en) 2018-03-22 2018-05-09 Bcm Specials Ltd Formulation
US20230312842A1 (en) * 2022-02-08 2023-10-05 Fujifilm Business Innovation Corp. Cellulosic particle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
US3780170A (en) * 1972-07-03 1973-12-18 Warner Lambert Co Tasteless methenamine mandelate
ES416148A1 (es) * 1972-12-26 1976-06-01 Willian H Rorer Inc Un procedimiento para preparar particulas antiacidas mejo- radas.
JPS5420572B2 (fi) * 1973-04-27 1979-07-24
US4292028A (en) * 1979-07-13 1981-09-29 Arthur Barr Cosmetic breath freshener and palate coolant composition and method of use
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
JPS6136217A (ja) * 1984-07-27 1986-02-20 Sankyo Co Ltd 経口投与用持効性製剤
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JPS6317821A (ja) * 1986-07-11 1988-01-25 Taisho Pharmaceut Co Ltd 矯味経口製剤
NZ221411A (en) * 1986-08-11 1989-10-27 Innovata Biomed Ltd Pharmaceutical compositions containing microcapsules and a surfactant

Also Published As

Publication number Publication date
IL86607A (en) 1992-03-29
GR3007542T3 (fi) 1993-08-31
ATE87471T1 (de) 1993-04-15
CA1317883C (en) 1993-05-18
EP0273890A1 (en) 1988-07-06
DE3785167T2 (de) 1993-07-15
US5085868A (en) 1992-02-04
AU609753B2 (en) 1991-05-09
DK668787D0 (da) 1987-12-18
DE3785167D1 (de) 1993-05-06
NO874960L (no) 1988-06-23
EP0273890B1 (en) 1993-03-31
JPS63166838A (ja) 1988-07-11
JP2778030B2 (ja) 1998-07-23
FI875645A0 (fi) 1987-12-21
NO874960D0 (no) 1987-11-27
NO177177B (no) 1995-04-24
PH25287A (en) 1991-04-30
IE873306L (en) 1988-06-22
SE8605515D0 (sv) 1986-12-22
ES2039480T3 (es) 1993-10-01
FI94923B (fi) 1995-08-15
FI94923C (fi) 1995-11-27
IE60149B1 (en) 1994-06-15
AU8199187A (en) 1988-06-23
NO177177C (no) 1995-08-02
DK668787A (da) 1988-06-23
HK66396A (en) 1996-04-26

Similar Documents

Publication Publication Date Title
FI94923B (fi) Menetelmä nestemäisen annostelumuodon valmistamiseksi farmaseuttisesti aktiivisen aineen oraalista antoa varten
DK16487D0 (da) Vacciner til oral indgift
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
NO875082L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
DK583789A (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
DK163959C (da) Farmaceutisk praeparat til oral indgift indeholdende cimetidin
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
DE68900994D1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
HUT53543A (en) Method for packing and/or feeding shape for therapeutical agents
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
NZ196288A (en) Pharmaceutical active substance administration
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
ES2019634B3 (es) Terapia con clorfeniramina.
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins
NO873940D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fosfin-gullforbindelser.
DK286986D0 (da) Enkeltdosisemballage til injektionsmedicin

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: ASTRA LAEKEMEDEL AKTIEBOLAG